You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 12, December 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (41)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Oncology
 •Head & Neck Cancer
 •Neoplasms of Head & Neck
 •Radiology of Head & Neck
 •Alert me on articles by topic

Diagnosis and Staging of Head and Neck Cancer

A Comparison of Modern Imaging Modalities (Positron Emission Tomography, Computed Tomography, Color-Coded Duplex Sonography) With Panendoscopic and Histopathologic Findings

Ercole Di Martino, MD; Bernd Nowak, MD; Hassan A. Hassan, MD; Ralf Hausmann; Gerhard Adam, MD; Udalrich Buell, MD; Martin Westhofen, MD

Arch Otolaryngol Head Neck Surg. 2000;126:1457-1461.

Objective  To compare the clinical value of positron emission tomography (PET) using fludeoxyglucose F 18, computed tomography (CT), color-coded duplex sonography (CCDS), and panendoscopy in the detection and staging of head and neck cancer.

Design  Prospective nonrandomized controlled study.

Setting  Medical school.

Patients  Convenience sample of 50 patients with suspected primary or recurrent head and neck cancer.

Intervention  Biopsy, tumor surgery.

Main Outcome Measures  Information of diagnostic procedures compared with histopathologic features.

Results  Both PET and panendoscopy had a sensitivity of 95% and 100% for detection of primary tumor or recurrent carcinomas, respectively. Specificity for PET and panendoscopy was 92% and 85% in primary tumors and 100% and 80% in recurrent carcinoma, respectively. Sensitivity of CCDS and CT was 74% and 68% in primary tumors and 67% and 63% in recurrent carcinomas, respectively. Specificity was 75% and 69% in primary tumors and 100% and 80% in recurrent neoplasms. When assessing neck nodes, all imaging procedures exhibited identical sensitivity (84%). Specificity was 90%, 96%, and 88% in PET, CT, and CCDS, respectively. In recurrent lymph node metastases, sensitivity was 100%, 67%, and 67% and specificity was 87%, 91%, and 87% for PET, CT, and CCDS, respectively.

Conclusions  Positron emission tomography was the most reliable imaging procedure in the detection of primary tumor and recurrent carcinomas localized in the head and neck region. Owing to its limited anatomical depiction, it cannot as yet replace other diagnostic procedures in preoperative planning but does contribute valuable complementary diagnostic information. Computed tomograpy may have difficulties in identifying recurrent carcinomas. For routine diagnosis of nodal spread in the neck, CCDS is recommended. Panendoscopy is a valuable diagnostic procedure that can provide key information in cases of superficial mucosal tumor involvement.


From the Departments of Ear, Nose, and Throat Diseases and Plastic Head and Neck Surgery (Drs Di Martino, Hassan, and Westhofen and Mr Hausmann), Nuclear Medicine (Drs Nowak and Buell), and Radiology (Dr Adam), the University of Aachen, Aachen, Germany.


RELATED ARTICLE

Archives of Otolaryngology–Head & Neck Surgery Reader's Choice: Continuing Medical Education
Arch Otolaryngol Head Neck Surg. 2000;126(12):1510.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Whole-Tumor Perfusion CT Parameters and Glucose Metabolism Measurements in Head and Neck Squamous Cell Carcinomas: A Pilot Study Using Combined Positron-Emission Tomography/CT Imaging
Bisdas et al.
Am. J. Neuroradiol. 2008;29:1376-1381.
ABSTRACT | FULL TEXT  

PET/CT: Form and Function
Blodgett et al.
Radiology 2007;242:360-385.
ABSTRACT | FULL TEXT  

Clinical Role of 18F-FDG PET/CT in the Management of Squamous Cell Carcinoma of the Head and Neck and Thyroid Carcinoma
Quon et al.
JNM 2007;48:58S-67S.
ABSTRACT | FULL TEXT  

18F-FDG PET/CT for Detecting Nodal Metastases in Patients with Oral Cancer Staged N0 by Clinical Examination and CT/MRI
Schoder et al.
JNM 2006;47:755-762.
ABSTRACT | FULL TEXT  

Controversies: Is There a Role for Positron-Emission Tomographic CT in the Initial Staging of Head and Neck Squamous Cell Carcinoma?
Mukherji and Bradford
Am. J. Neuroradiol. 2006;27:243-245.
FULL TEXT  

The Role of Positron Emission Tomography and Computed Tomography Fusion in the Management of Early-Stage and Advanced-Stage Primary Head and Neck Squamous Cell Carcinoma
Ha et al.
Arch Otolaryngol Head Neck Surg 2006;132:12-16.
ABSTRACT | FULL TEXT  

Unknown Primary Tumors: Detection with Dual-Modality PET/CT--Initial Experience
Gutzeit et al.
Radiology 2005;234:227-234.
ABSTRACT | FULL TEXT  

Clinical Applications of Tumor Volume Measurements for Predicting Outcome in Patients with Squamous Cell Carcinoma of the Upper Aerodigestive Tract
Mukherji et al.
Am. J. Neuroradiol. 2004;25:1425-1432.
ABSTRACT | FULL TEXT  

Clinical Applications of PET in Oncology
Rohren et al.
Radiology 2004;231:305-332.
ABSTRACT | FULL TEXT  

Why Most PET of Lung and Head-and-Neck Cancer Will Be PET/CT
Goerres et al.
JNM 2004;45:66S-71.
ABSTRACT | FULL TEXT  

Evaluation of Head and Neck Squamous Cell Carcinoma After Treatment
Mukherji and Wolf
Am. J. Neuroradiol. 2003;24:1743-1746.
FULL TEXT  

Imaging of malignant sinus tumours
Rankin
Imaging 2003;15:127-140.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.